Sydney Emerging Infectious Diseases and Biosecurity Institute, the University of Sydney, Sydney, Australia.
J Clin Microbiol. 2013 Jun;51(6):1818-25. doi: 10.1128/JCM.00200-13. Epub 2013 Apr 3.
Numerous reports have documented isolated transmission events or clonal outbreaks of multidrug-resistant Mycobacterium tuberculosis strains, but knowledge of their epidemic spread remains limited. In this study, we evaluated drug resistance, strain diversity, and clustering rates in patients diagnosed with multidrug-resistant (MDR) tuberculosis (TB) at the National Health Laboratory Service (NHLS) Central TB Laboratory in Johannesburg, South Africa, between March 2004 and December 2007. Phenotypic drug susceptibility testing was done using the indirect proportion method, while each isolate was genotyped using a combination of spoligotyping and 12-MIRU typing (12-locus multiple interspersed repetitive unit typing). Isolates from 434 MDR-TB patients were evaluated, of which 238 (54.8%) were resistant to four first-line drugs (isoniazid, rifampin, ethambutol, and streptomycin). Spoligotyping identified 56 different strains and 28 clusters of variable size (2 to 71 cases per cluster) with a clustering rate of 87.1%. Ten clusters included 337 (77.6%) of all cases, with strains of the Beijing genotype being most prevalent (16.4%). Combined analysis of spoligotyping and 12-MIRU typing increased the discriminatory power (Hunter Gaston discriminatory index [HGDI] = 0.962) and reduced the clustering rate to 66.8%. Resolution of Beijing genotype strains was further enhanced with the 24-MIRU-VNTR (variable-number tandem repeat) typing method by identifying 15 subclusters and 19 unique strains from twelve 12-MIRU clusters. High levels of clustering among a variety of strains suggest a true epidemic spread of MDR-TB in the study setting, emphasizing the urgency of early diagnosis and effective treatment to reduce transmission within this community.
大量报告记录了耐多药结核分枝杆菌(Mycobacterium tuberculosis)菌株的孤立传播事件或克隆暴发,但对其流行传播的了解仍然有限。在这项研究中,我们评估了 2004 年 3 月至 2007 年 12 月期间在南非约翰内斯堡国家卫生实验室服务(National Health Laboratory Service,NHLS)中央结核病实验室诊断为耐多药(MDR)结核病(TB)的患者的耐药性、菌株多样性和聚类率。采用间接比例法进行表型药敏试验,同时采用 spoligotyping 和 12-MIRU 分型(12 个位点多位点重复单位分型)组合对每个分离株进行基因分型。评估了 434 例 MDR-TB 患者的分离株,其中 238 例(54.8%)对异烟肼、利福平、乙胺丁醇和链霉素 4 种一线药物耐药。 spoligotyping 鉴定了 56 种不同的菌株和 28 个大小不等的簇(每个簇 2 至 71 例),聚类率为 87.1%。10 个簇包含所有病例的 337 例(77.6%),其中北京基因型菌株最为流行(16.4%)。 spoligotyping 和 12-MIRU 分型联合分析提高了区分能力(Hunter Gaston 区分指数[HGDI]=0.962),将聚类率降低至 66.8%。24-MIRU-VNTR(可变数串联重复)分型方法进一步提高了北京基因型菌株的分辨率,从 12 个 12-MIRU 簇中鉴定出 15 个亚簇和 19 个独特菌株。多种菌株之间的高度聚类表明 MDR-TB 在研究环境中确实存在流行传播,强调了早期诊断和有效治疗的紧迫性,以减少该社区内的传播。